Subject: This is Why PSID will Rebound.. and Soon

SCV Client Spotlight
This is Why PSID will Rebound... and Soon
Hot Stock to WatchHot Stock to Watch

Company: PositiveID Corporation (OTCQB: PSID)


Price: 0.29

Change (%): + 0.00 (0.00)

Volume: 60,043
PSID Chart

PositiveID’s New Firefly Bio-threat Detection Device Could Save Us All

After the recent Obama ricin letters incident, public awareness surrounding biological threats has definitely heightened and more than before, there is a need for rapid, accurate testing in the field to protect against the growing number of potential bio hazards.

Meet Firefly
PositiveID Corporation (OTCBB: PSID) recently announced they are developing the Firefly Dx system, a new device intended to provide fast, accurate bio-threat detection. Firefly is a hand-held pathogen detection system designed to purify and analyze a sample and deliver test results in less than thirty minutes. The device will employ single-use, disposable cartridges with tracking RFID chips. Firefly will process data in real time which data can then be sent via wireless communication to SMART phones or personal computers with a specialized, mobile application and cloud-based data sharing and storage.

The Brilliance of Firefly
Firefly aims to combine PositiveID’s patented molecular diagnostic technology found in its M-BAND airborne bio-threat detector with the Dragonfly Rapid MDx Cartridge-based diagnostic system into a portable, handheld device, so it can be used practically anywhere and with minimal training.

Firefly Will Find It
Firefly is expected to be able to identify virtually any biological agent once the Company has the specific assay developed, including the identification of various forms of Influenza, E. coli, HPV, among other things. In addition, it can also detect biological warfar agents (Ba, Yp, Ft) and antibiotic resistant bacteria (MRSA). Firefly is expected to prove useful for a number of applications from detecting environmental bacteria and antibiotic-resistant bacteria to bio-threat agents and even for use in forensic science. The incorporated, multiplex polymerase chain reaction (“PCR”) assay will be designed to test for multiple, user-defined targets, all from a single sample.

Plus, Firefly uses TaqMan®-based PCR assays and real-time detection, which means it will be able to measure altered gene expression levels like those found in radiation exposure and cancer.

Multiple Sample Types
Not only will Firefly test for numerous pathogens, but it also will be designed to process a variety of sample types such as whole blood, nasal swabs, buccal (cheek) swabs, urine and environmental field samples. Firefly is expected to improve the ease of testing by accepting a multitude of different sample types.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks